Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer.

Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer. Cancer Discov. 2022 11 02; 12(11):2586-2605.

View in: PubMed